Home › Funds › PERCEPTIVE ADVISORS LLC › IRD
PERCEPTIVE ADVISORS LLC position in IRD
OPUS GENETICS INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 9,000,000 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$43.6M, representing 0.84% of its reported portfolio and ranking #28 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed IRD holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's IRD position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in IRD in Q1 2025 at 4,325,000 shares (US$4.2M). The position peaked in Q3 2026 at 9,000,000 shares, worth US$43.6M. Across 6 filings, PERCEPTIVE ADVISORS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 9,000,000 shares valued at US$43.6M. Notable position changes include a 58% trim in Q1 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 4.33M | $4.25M | New |
| Q2 2025 | 4.33M | $4.07M | Hold |
| Q3 2025 | 4.33M | $7.14M | Hold |
| Q4 2025 | 4.33M | $8.69M | Hold |
| Q1 2026 | 1.84M | $8.35M | Reduce |
| Q3 2026 | 9.00M | $43.56M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include BIOS Capital Management, LP (US$17.83B), Caligan Partners LP (US$28.9M), Cormorant Asset Management, LP (US$26.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- BIOS Capital Management, LP 3.68M sh · $17.83B · Q3 2026
- Caligan Partners LP 5.96M sh · $28.85M · Q3 2026
- Cormorant Asset Management, LP 5.50M sh · $26.62M · Q3 2026
- Nantahala Capital Management, LLC 4.57M sh · $22.12M · Q3 2026
- Boxer Capital Management, LLC 4.53M sh · $21.94M · Q3 2026
- Trails Edge Capital Partners, LP 2.41M sh · $11.67M · Q3 2026
- Blue Owl Capital Holdings LP 969.61K sh · $4.69M · Q3 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- GREAT POINT PARTNERS LLC 776.88K sh · $3.76M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 514.11K sh · $2.49M · Q3 2026
- Propel Bio Management, LLC 270.04K sh · $1.31M · Q3 2026
- Stonepine Capital Management, LLC 98.15K sh · $475.03K · Q3 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held IRD?
PERCEPTIVE ADVISORS LLC has disclosed IRD holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
What is PERCEPTIVE ADVISORS LLC's current position in IRD?
As of Q3 2026, PERCEPTIVE ADVISORS LLC holds 9.00M shares of IRD (OPUS GENETICS INC), valued at $43.56M, representing 0.84% of its reported portfolio and ranking #28.
Has PERCEPTIVE ADVISORS LLC been buying or selling IRD?
In the latest 13F filing (Q3 2026), PERCEPTIVE ADVISORS LLC newly opened its position in IRD. The position peaked in Q3 2026 at 9.00M shares.
Which other funds hold IRD?
Other major institutional holders of IRD include BIOS Capital Management, LP, Caligan Partners LP, Cormorant Asset Management, LP, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.